RT Journal Article
SR Electronic
T1 ROLE OF LUNG ULTRASOUND FOR THE ETIOLOGICAL DIAGNOSIS OF COMMUNITY- ACQUIRED PNEUMONIA IN CHILDREN: A PROSPECTIVE STUDY
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.31.20223867
DO 10.1101/2020.10.31.20223867
A1 Buonsenso, Danilo
A1 Musolino, Annamaria
A1 Ferro, Valentina
A1 De Rose, Cristina
A1 Morello, Rosa
A1 Ventola, Chiara
A1 Liotti, Flora Marzia
A1 Chiaretti, Antonio
A1 Biasucci, Daniele Guerino
A1 Spanu, Teresa
A1 Sanguinetti, Maurizio
A1 Valentini, Piero
YR 2020
UL http://medrxiv.org/content/early/2020/11/04/2020.10.31.20223867.abstract
AB Objective and design Our prospective study is one of the largest prospective study assessing the role of detailed lung ultrasound features to discriminate the etiological diagnosis of Community acquired pneumonia (CAP) in children.Methodology We prospectively analysed patients aged from 1 month to 17 years admitted between March 2018 and April 2020 who were hospitalized for CAP. For all patients included in the study, history, clinical parameters, microbiological data, and lung ultrasound data were collected.Patients were stratified into three main groups (“bacterial”, “viral”, “atypical”) according to the presumed microbial aetiology and lung ultrasound findings evaluated according to the aetiological group.Results We found that some ultrasound findings as size, number and distribution of consolidations, the position and motion of air bronchograms, pleural effusions and distribution of vertical artifacts significantly differ (p < 0.05) in children with bacterial, viral and atypical CAP. Conversely, clinical parameters and laboratory were not able to significantly distinguish between these groups. Chest x-ray, despite being still widely used, was the less useful tool in this discrimination.Conclusion Our study provides a detailed analysis of LUS features able to predict the etiology CAP in children. These findings may help the physicians to better manage a child with CAP and to offer personalized approach, from diagnosis to treatment and follow-up.Competing Interest StatementThe authors have declared no competing interest.Funding Statementnothing to declareAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board and Ethic Committee (prot.36173/19 ID2729)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript and note links below.